Equity
Caris Life Sciences, Inc. (CAI) perpetual futures
Caris Life Sciences is a TechBio company using AI to offer molecular profiling services, including tissue and blood-based tests, for clients in the US and internationally.
+1.5%NASDAQ closed
Price chart
Interactive TradingView chart
TradingView symbol NASDAQ:CAI
Loads TradingView's third-party widget (about 1 MB) on demand.
Auto: underlying reference priceOpen in TradingView
Trading data
Perpetual market activity
0/1 live markets
Trading data
Perpetual market activity
Venues
1
Live markets
0/1
24h volume
-
Open interest
-
Best liquidity
-
Tightest spread
-
Highest volume
-
Settlement mix
USDT · 1/1
Perp/spot vol.
-
OI / float
-
Spot performance
1D+1.48%
5D-4.25%
1M+10.80%
6M+40.95%
YTD+1.93%
1Y-16.54%
BingXBest venues for this underlying
Best liquidity
-No live data-
Tightest spread
-No live data-
Highest volume
-No live data-
Company data
Company fundamentals
Updated 3h ago
Company data
Company fundamentals
Market cap
$7.8B
Updated 3h ago
Revenue
$989.6M
Trailing 12 months
Revenue growth
+27%
Next fiscal year
Profit margin
+10.6%
P/E
73.9
Peer P/E 30.1
Free cash flow
$146.5M
Trailing 12 months
More metrics
Net income
$105.1M
Trailing 12 months
P/S
7.9
Peer P/E
30.1
Similar listed perps
Revenue estimate
$1B
Next fiscal year
Earnings
2026-11-04
Revenue est. $255.5M · Updated 3h ago
Dividend
-
Fundamental detail
Annual + quarterlyLatest revenue$812M
Net margin-66.2%
Free cash flow$66.9M
Net debt-$418.8M
PeriodRevenueGrowthNet incomeFCF
2019$416.5M-4%$31M-$65.1M
2020$294M-29%$27.7M$57.6M
2022$258.5M-12%-$320.8M-$328M
2023$306.1M+18%-$341.4M-$298.4M
2024$412.3M+35%-$281.9M-$253.6M
2025$812M+97%-$538M$66.9M
PeriodGross marginOperating marginNet marginROEROA
2019+48.1%+31.3%+7.4%+4.5%+1.1%
2020+62.6%+47.3%+9.4%+3.9%+1.1%
2022+31.0%-122.2%-124.1%+18.8%-44.7%
2023+29.2%-104.4%-111.5%+15.9%-82.7%
2024+43.4%-62.4%-68.4%+11.3%-82.0%
2025+66.4%+5.6%-66.2%-93.2%-47.8%
PeriodCashDebtNet debtCurrent ratio
2019$46.5M$2.1B$2.1B1.74
2020$53.5M$1.7B$1.7B0.67
2022$107.2M$270.9M$163.7M3.77
2023$56.4M$217.3M$160.9M2.55
2024$64M$424.3M$360.3M1.30
2025$797.8M$379M-$418.8M7.85
PeriodMarket capEnterprise valueP/SP/E
2019$504.3M$2.6B1.216.3
2020$502.6M$2.2B1.718.1
2022$7.1B$7.3B27.6-17.8
2023$7.1B$7.3B23.3-15.4
2024$7.1B$7.5B17.3-10.4
2025$7.6B$7.2B9.4-14.1
PeriodRevenueGrowthNet incomeFCF
Q3 2024$101.6M+1%-$67.7M-$71.3M
Q4 2024$129.9M--$36.9M-$41.2M
Q1 2025$120.9M+50%-$102.6M-$34M
Q2 2025$181.4M+81%-$71.8M$5.9M
Q3 2025$216.8M+113%$24.3M$55.3M
Q4 2025$292.9M+125%$82M$39.7M
Q1 2026$216.2M+79%-$510K$22.5M
Q2 2026$263.7M+45%-$637K$28.9M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+43.7%-59.9%-66.6%0.0%0.0%
Q4 2024+54.4%-28.5%-28.4%+13.3%-10.7%
Q1 2025+47.2%-47.9%-84.8%+3.9%-35.2%
Q2 2025+62.7%+9.9%-39.6%-15.9%-7.5%
Q3 2025+68.0%+15.1%+11.2%+5.1%+2.5%
Q4 2025+75.4%+30.2%+28.0%+14.2%+7.3%
Q1 2026+65.4%+2.4%-0.2%-0.1%0.0%
Q2 2026+68.1%+10.2%-0.2%-0.1%-0.1%
PeriodCashDebtNet debtCurrent ratio
Q3 2024---0.00
Q4 2024$64M$424.3M$360.3M1.30
Q1 2025$31.2M$419.8M$388.6M1.05
Q2 2025$718.9M$419M-$300M9.24
Q3 2025$753.2M$426.7M-$326.5M9.93
Q4 2025$797.8M$379M-$418.8M7.85
Q1 2026$821.1M$431M-$390.2M7.05
Q2 2026$690.9M$452.4M-$238.5M5.53
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$7.9B$077.5-21.2
Q4 2024$7.9B$8.2B60.6-31.8
Q1 2025$7.1B$7.5B59.0-17.5
Q2 2025$7.2B$6.9B39.5-3.5
Q3 2025$8.5B$8.2B39.487.9
Q4 2025$7.6B$7.2B26.023.3
Q1 2026$5.1B$4.7B23.4-2,483.3
Q2 2026$5B$4.8B19.1-1,937.0
Refreshed 3h ago
Charts: revenue, profit, cash flow & valuation
CashDebt
Gross marginOperating marginNet margin
P/EP/S
CashDebt
Gross marginOperating marginNet margin
P/EP/S
Next catalyst
Catalysts
Next catalyst
Catalysts
Earnings
2026-11-04
Revenue est. $255.5M · Updated 3h ago
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6DateEPS estimateRevenue estimateGrowthAnalysts
FY 20260.12$1B+27%8
FY 20270.35$1.2B+51%8
FY 20280.52$1.4B+75%8
FY 20290.60$1.6B+101%5
FY 20300.72$1.9B+129%5
Q1 20270.04$263.1M+22%2
Company events
62026-11-04EarningsActual - / Estimate 0.03-
2026-08-05EarningsActual -0 / Estimate 0.01Miss
2026-05-07EarningsActual -0 / Estimate -0.02Beat
2026-02-26EarningsActual 0.28 / Estimate 0.01Beat
2025-11-05EarningsActual 0.08 / Estimate -0.08Beat
2025-08-12EarningsActual -0.54 / Estimate -0.21Miss
Peer comparison
Similar listed perpsAnalysts
PendingNo analyst data available yet.
Ownership
CAI-PERPOwnership data is being populated.
Filings
PendingNo filings available yet.
Transcripts
PendingNo transcripts available yet.
Company news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
Analyst track record
How the analysts covering CAI have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 56 | 70 |
| Analysts | 14 | 17 |
| Buy / hold / sell | 41 / 15 / 0 | 55 / 15 / 0 |
| Upgrades / downgrades / initiations | 0 / 1 / 6 | 0 / 1 / 14 |
| Price targets hit / missed | 21 / 31 (40%) | 21 / 45 (32%) |
| Avg. return after a rating (TipRanks) | -3.7% | -7.2% |
| Best / worst call | +35.0% / -37.0% | +35.0% / -37.0% |
After buy calls on this stock: median 21-day move +1.6% vs S&P 500 -0.1% (n = 55)
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Sep 9, 2026 | Unknown AnalystUBS | HoldInitiated | $28.00 | article ↗ |
| Aug 7, 2026 | Mark MassaroBTIG | BuyReiterated | $33.00 | article ↗ |
| Aug 6, 2026 | Michael RyskinBank of America Securities | BuyMaintained | – | article ↗ |
| Aug 6, 2026 | Casey WoodringJ.P. Morgan | BuyMaintained | $25.00 | article ↗ |
| Aug 6, 2026 | Vijay KumarEvercore ISI | BuyMaintained | $26.00 | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data via FMP · computed Oct 2, 2026 · 56 ratings
Embed this asset
<a href="https://perpequities.com/stocks/cai-perp"><img src="https://perpequities.com/badge/cai-perp.svg" width="240" height="64" alt="CAI perpetuals · perpequities.com" loading="lazy"></a>